NCT05160532View on ClinicalTrials.gov

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Knee Osteoarthritis

Interventions

DRUG

Placebo

5ml of normal saline (NS)

DRUG

Dextrose prolotherapy (DPT)

25% dextrose, mixing 2.5ml of sterile water and 2.5ml of 50% dextrose.

Trial Locations (1)

85260

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT05160532 - Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis | Biotech Hunter | Biotech Hunter